Crinetics Pharmaceuticals (CRNX) Market Cap

Price: $32.6
Market Cap: $3.03B
Avg Volume: 1.01M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.375
52W Range: $24.1-62.53
Website: Crinetics Pharmaceuticals

Market Cap Overview

Market Cap

$3.03B

Share Price

$32.6

Shares Outstanding

93.05M


What is Crinetics Pharmaceuticals's Market Cap?

Crinetics Pharmaceuticals's current Market Cap as of today is $3.03B.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Crinetics Pharmaceuticals, the market cap is calculated as $32.6 x 93.05M shares = $3.03B.

As a Mid Cap company, Crinetics Pharmaceuticals is a medium-sized company with significant growth potential.

Crinetics Pharmaceuticals Historical Market Cap

$6.00B$6.00B$5.00B$5.00B$4.00B$4.00B$3.00B$3.00B$2.00B$2.00B$1.00B$1.00B$0.00$0.00Market CapJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Crinetics Pharmaceuticals Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Crinetics Pharmaceuticals, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$5.00B$5.00B$4.00B$4.00B$3.00B$3.00B$2.00B$2.00B$1.00B$1.00B$0.00$0.00ValueJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Crinetics Pharmaceuticals's enterprise value as of December 31, 2024 (Q4 2024) is calculated as:

  • Market Cap: $3.03B
  • Total Debt: $51.72M
  • Cash and Equivalents: $264.55M
  • Enterprise Value: $4.47B

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A higher enterprise value suggests significant debt levels.

Crinetics Pharmaceuticals Annual Market Cap History

Year Market Cap Change
2025 $3.03B -26.56%
2024 $4.13B 99.91%
2023 $2.07B 117.20%
2022 $951.27M -12.88%
2021 $1.09B 154.17%
2020 $429.62M -29.17%
2019 $606.55M 66.57%
2018 $364.14M 7.05%
2017 $340.15M 0.00%
2016 $340.15M N/A

Frequently Asked Questions

Crinetics Pharmaceuticals's current market capitalization is $3.03B. This makes it a Mid Cap company, calculated by multiplying its current stock price of $32.6 by 93.05M outstanding shares.

Crinetics Pharmaceuticals's enterprise value is $4.47B. This is calculated by adding total debt ($51.72M) to market cap and subtracting cash and equivalents ($264.55M). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Crinetics Pharmaceuticals has 93.05M shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Crinetics Pharmaceuticals is classified as a Mid Cap company. Mid-cap companies are established companies with market caps between $2 billion and $10 billion.

Crinetics Pharmaceuticals's market cap is calculated by multiplying its current stock price ($32.6) by its total number of outstanding shares (93.05M). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for CRNX.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio